#United States #Austin #Clinical Trials #Oracle #ACRN

Oracle's Partnership with ACRN

In a groundbreaking initiative aimed at improving healthcare in Africa, Oracle has partnered with the Africa Clinical Research Network (ACRN) to kickstart its first clinical trial titled the PROtective Testing to Enhance Clinical Triage of Pre-eclampsia in Africa (PROTECT-Africa). Launched in February 2026, this trial is set to take place across Zimbabwe, Rwanda, and Tanzania, where it aims to recruit 1,106 pregnant women. The primary goal of the trial is to define and validate placental biomarkers that can predict the likelihood of severe pre-eclampsia, a serious pregnancy complication that contributes to high rates of maternal and fetal morbidity

Why This Trial Matters

Pre-eclampsia, along with its severe complications such as eclampsia and HELLP syndrome, remains a leading cause of maternal and fetal health issues worldwide. Particularly in resource-limited settings in Africa, the lack of adequate research has led to significant knowledge gaps and treatment delays. The partnership between Oracle and ACRN seeks to close this gap by employing innovative point-of-care platforms for testing, which promise efficiency and accessibility in clinical evaluation.

Empowering Local Researchers

The ACRN, an African-led organization, is dedicated to empowering local clinicians and researchers. According to Tariro Makadzange, the CEO of ACRN, the collaboration with Oracle's state-of-the-art clinical trial and safety solutions will enhance the speed, efficiency, and transparency of trials, with a steadfast focus on patient welfare. This partnership brings much-needed modernity to the healthcare landscape, enabling researchers to conduct studies that directly cater to the health needs of African communities.

Oracle's Cloud Platform

Oracle's integrated cloud solutions, including Oracle Clinical One and Argus Safety, aim to streamline the clinical trial process. By providing tools for automating workflows, managing critical data, and optimizing trials, Oracle supports ACRN's mission to deliver patient-centric research initiatives that can foster rapid delivery of health innovations across the continent.

Looking Toward the Future

Currently, less than three percent of global clinical trials are conducted in Africa — a statistic that ACRN aims to change. The organization plans to develop a pan-African clinical research ecosystem to promote better representation of African populations in medical research. This extensive initiative involves a network of 59 clinical sites across 14 countries, which will enable further research focused on global health in line with the needs of African communities.

With the backing of Oracle’s advanced clinical solutions, ACRN is also gearing up to launch additional trials this year aimed at addressing various global health challenges. This approach is set to improve data quality and connectivity while maintaining the highest levels of patient safety, essential for fostering trust in clinical research initiatives.

Conclusion

The Oracle and ACRN partnership showcases a promising pathway for transforming clinical research in Africa. By addressing long-standing disparities in healthcare research, this collaboration not only aims to enhance maternal health outcomes but also to build a sustainable clinical research environment that paves the way for future medical innovations in the region. With initiatives like this, Africa may begin to witness an uptick in research-driven healthcare solutions that reflect the unique health challenges faced by its populations. In a realm where effort and expertise converge, the potential for impactful change becomes increasingly tangible.